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Abstract
Background: The study was conducted between 2000 and 2003 on 750 human subjects, yielding
850 strains of staphylococci from clinical specimens (575), nasal cultures of hospitalized patients
(100) and eye & nasal sources of hospital workers (50 & 125 respectively) in order to determine
their epidemiology, acquisition and dissemination of resistance genes.
Methods: Organisms from clinical samples were isolated, cultured and identified as per the
standard routine procedures. Susceptibility was measured by the agar diffusion method, as
recommended by the Nat ional Committee for Clinical Laboratory Standards (NCCLS). The
modified method of Birnboin and Takahashi was used for isolation of plasmids from staphylococci.
Pulsed-field gel electrophoresis (PFGE) typing of clinical and carrier Methicillin resistant
Staphylococcus aureus (MRSA) strains isolated during our study was performed as described
previously.
Results:  It was shown that 35.1% of Staphylococcus aureus and 22.5% of coagulase-negative
staphylococcal isolates were resistant to methicillin. Highest percentage of MRSA (35.5%) was
found in pus specimens (n = 151). The multiple drug resistance of all MRSA (n = 180) and Methicillin
resistant Coagulase-negative Staphylococcus aureus (MRCNS) (n = 76) isolates was detected. In case
of both methicillin-resistant as well as methicillin-sensitive Saphylococcal isolates zero resistance
was found to vancomycin where as highest resistance was found to penicillin G followed by
ampicillin. It was shown that the major reservoir of methicillin resistant staphylococci in hospitals
are colonized/infected inpatients and colonized hospital workers, with carriers at risk for
developing endogenous infection or transmitting infection to health care workers and patients. The
results were confirmed by molecular typing using PFGE by SmaI-digestion.
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It was shown that the resistant markers G and T got transferred from clinical S. aureus (JS-105) to
carrier S. aureus (JN-49) and the ciprofloxacin (Cf) and erythromycin (E) resistance seemed to be
chromosomal mediated. In one of the experiments, plasmid pJMR1O from Staphylococcus aureus
coding for ampicillin (A), gentamicin (G) and amikacin (Ak) resistance was transformed into
Escherichia coli. The minimal inhibitory concentrations (MICs) for A and G were lower in E. coli than
in S. aureus. However, the MIC for Ak was higher in E. coli transformants than in S. aureus.
Conclusion: There is a progressive increase in MRSA prevalence and multi-drug resistance in
staphylococci. Vancomycin is still the drug of choice for MRSA infections. The major reservoir of
methicillin resistant staphylococci in hospitals is colonized/infected inpatients and colonized
hospital workers. Resistance transfer from staphylococci to E. coli as well as from clinical to carrier
staphylococci due to antibiotic stress seemed to be an alarming threat to antimicrobial
chemotherapy.
Background
Staphylococci are one of the important causes of human
infections but are also found as non-pathogenic microor-
ganisms in human samples [1-5]. The spectrum of S.
aureus infections includes toxic shock syndrome [6], food
poisoning, meningitis [6,7] as well as dermatological dis-
orders ranging from minor infections and eczema to blis-
ters and scalded skin syndrome [8]. Recent reports have
begun to document infections caused by Staphylococcus
epidermidis, such as bacterial endocarditis [9] prosthetic
heart valve endocarditis [10], bacteraemia, surgical
wound infections [11], intravascular catheters [12], post-
operative endophathalmitis [13], conjunctivitis and kera-
titis [14]. Several other coagulase negative staphylococci
(CNS) species have been implicated at low incidence in a
variety of infections. The CNS species Staphylococcus sapro-
phyticus was often regarded as a more important oppor-
tunistic pathogen than S. epidermidis in human urinary
tract infections (UTIs), especially in young sexually active
females. It was considered to be the second most common
cause of acute cystatitis or pyelonephritis in these patients
[15,16]. The major reservoir of Staphylococci in hospitals
are colonized/infected in-patients and colonized hospital
workers, with carriers at risk for developing endogenous
infection or transmitting infection to health care workers
and patients [3,17-23], while transient hand carriage of
the organism on the hands of health care workers account
for the major mechanism for patient to patient transmis-
sion [24].
Methicillin-resistant strains of staphylococci were identi-
fied immediately upon the introduction of methicillin
into clinical practice. Methicillin-resistant S. aureus
(MRSA) was initially identified for the first time in 1961
by Jevons [25,26]. Since then strains of methicillin-resist-
ant Staphylococcus aureus and methicillin-resistant coagu-
lase-negative staphylococci have spread worldwide
[27,28] and have become established inside and outside
of the hospital environment [29]. Already multiresistant
to different classes of antibiotics, MRSA had been reported
to acquire resistance to gentamicin and related aminogly-
cosides [30] therefore the treatment of infections due to
these organisms and their eradication is very difficult.
Constant monitoring of these strains is essential in order
to control their spread in the hospital environment and
transmission to the community.
The present study was undertaken with the aim of deter-
mining epidemiology of clinical and carrier staphylococci
and molecular studies of their acquisition and dissemina-
tion of resistance in a hospital setting in northern India.
Materials and methods
The study population (n = 750) was divided into healthy
personnel (n = 175) and patients (n = 575) (including 50
medical personnel attending wound infections). For the
healthy personnel, 125 hospital workers contributed
nasal swabs and 50 hospital works contributed ocular
swabs. None of the healthy personnel had taken any kind
of antibiotics 7 days before the time of specimen collec-
tion. For the patients, 50 patients with wound infections
admitted in Orthopedic Surgical Ward of J.N. Medical
College, Aligarh Muslim University, Aligarh India, con-
tributing nasal swabs besides pus culture and 525 subjects
contributing different clinical sources were included.
Informed consent was obtained from all the subjects
before sample collection. The Ethical committees of Sher-
e-Kashmir Institute of Medical Sciences, Srinagar and J.N.
Medical College, Aligarh Muslim University, Aligarh India
approved the study.
Specimen collection
Organisms from clinical samples were cultured as per the
routine procedures. The anterior nares were sampled as
follows. A sterile cotton-tipped swab was moistened in a
culture tube containing 2 ml of 0.1% buffered Tween 80.
The swab was wrung out within the tube, swirled inside
the anterior nares for five clockwise, and five counter
clockwise rotations, reintroduced into the culture tube
and wrung out. The ocular swabs were obtained asAnnals of Clinical Microbiology and Antimicrobials 2006, 5:22 http://www.ann-clinmicrob.com/content/5/1/22
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described previously [31]. Swabs were deposited in tubes
containing 2 ml of detergent fluid (0.1% buffered Tween
80) serially diluted in 10 fold steps. 40 µl per dilution was
then drop plated onto the 5% sheep blood agar plates and
mannitol salt agar plates (Hi-Media Mumbai, India), and
the plates were incubated for 24 h at 35°C and observed
or the growth of suspected Staphylococci colonies. After
the identity of the cultures was confirmed according to
Bergey's manual including Gram's staining, catalase and
coagulase test (slide and tube methods) [32,33], they were
stored at -70°C in freezer vials containing 15% glycerol
for further analysis.
Antimicrobial susceptibility test
Susceptibility was measured by the agar diffusion
method, as recommended by the National Committee for
Clinical Laboratory Standards (NCCLS) [34], with the fol-
lowing discs; amikacin (Ak), 30 µg; ampicillin (A), 10 µg;
cefazolin (Cz), 30 µg; cephalexin (Ce), 30 µg; cephotax-
ime (Cp), 30 µg; chloramphenicol (C), 30 µg; cipro-
floxacin (Cf), 5 µg; clinadamycin (Cd), 2 µg; Co-
trimoxazole (Co), 25 µg; fusidic acid (Fc), 10 µg; gen-
tamicin (G), 10 µg; Imipenem (I), 10 µg; methicillin (M),
5 µg; penicillin G (P), 10 U; rifampin (R), 5 µg; roxithro-
mycin (Ro), 30 µg; Tetracycline (T), 30 µg; and vancomy-
cin, 30 µg; (Hi Media Mumbai, India). Methicillin-
resistant Staphylococci were also tested for oxacillin resist-
ance using the oxacillin-salt screening test performed
according to NCCLS guidelines [35]. S. aureus ATCC®
29213, S. aureus ATCC® 43300; (American Type Culture
Collection Manassas, VA USA) were used as the positive
and negative controls respectively.
Plasmid isolation, transformation and conjugation
The modified method of Birnboin and Takahashi was
used for isolation of plasmids from staphylococci [36,37].
The resulting samples were separated on agarose gels and
visualized under UV illumination after staining with
ethidium bromide [38]. In order to study the transfer of
resistance genes between different species of bacteria,
transformation of plasmid DNA from Staphylococcus
aureus (JMR-10) (AR, GR, AkR) (Table 2) to Escherichia coli
(DH5α) (AS, GS, AkS) was performed as studied previously
[39]. Plasmid DNA was isolated from JMR-10 strain and
transformed to DH5α. Transformation was tested by anti-
biotic sensitivity tests as studied previously [34].
For resistance transfer to be studied through cell – to – cell
contacts between clinical and carrier S. aureus strains, the
conjugation was performed through mixed culture tests as
studied previously [33,39]. Here S. aureus strains were iso-
lated from a patient having postoperative ocular infection
Table 1: Resistance profilesa of staphylococcal isolates (n = 850) from eyes and other clinical sources in health and disease
Antimicrobial Agent
(n = 18)b
Percentage of Resistancec Displayed by
S. aureus
n = 513 (%)
Clinical S. arueus
n = 338(%)
Carrier S. arueus
n = 175 (%)
Coagulase-negative
Staphylococci (CNS)
n = 337 (%)
Clinical CNS
n = 237 (%)
Carrier CNS
n = 100 (%)
Amikacin 65 (12.7) 47 (13.9) 18 (10.3) 27 (8.0) 27 (11.4) 0 (0.0)
Ampicillin 413 (80.5) 275 (81.4) 138 (78.8) 241 (71.5) 183 (77.2) 58 (58.0)
Cefazolin 190 (37.0) 131 (38.8) 59 (33.7) 80 (23.7) 64 (27.0) 16 (16.0)
Cephalexin 237 (46.2) 165 (48.8) 72 (41.1) 86 (25.5) 68 (28.7) 18 (18.0)
Cephotaxime 207 (40.3) 145 (42.9) 62 (35.4) 78 (23.2) 68 (28.7) 16 (16.0)
Chloramphenicol 22 (4.3) 16 (4.7) 6 (3.4) 17 (5.0) 12 (5.1) 5 (5.0)
Ciprofloxacin 103 (20.1) 81 (24.0) 22 (12.6) 75 (22.2) 56 (23.6) 19 (19.0)
Clindamycin 79 (15.4) 60 (17.7) 19 (10.9) 71 (21.1) 56 (23.6) 15 (15.0)
Co-trimoxazoled 256 (50.0) 175 (51.8) 81 (46.3) 136 (40.3) 104 (43.9) 32 (32.0)
Fusidic acid 18 (3.5) 14 (4.1) 4 (2.3) 12 (3.6) 8 (3.4) 4 (4.0)
Gentamicin 172 (33.5) 122 (36.1) 50 (28.6) 90 (26.7) 72 (30.4) 18 (18.0)
Imipenem 136 (26.5) 97 (28.7) 39 (23.3) 68 (20.2) 54 (22.8) 14 (14.0)
Methicilline 180 (35.1) 128 (37.9) 52 (29.7) 76 (22.5) 63 (26.6) 13 (13.0)
Penicillin G 472 (92.0) 313 (92.6) 159 (90.9) 303 (89.9) 222 (93.7) 81 (81.0)
Rifampin 97 (18.9) 68 (20.1) 29 (16.6) 41 (12.2) 33 (13.9) 8 (8.0)
Roxithromycin 146 (24.6) 103 (30.5) 43 (24.6) 53 (15.7) 48 (20.2) 8 (8.0)
Tetracycline 61 (11.9) 43 (12.7) 18 (10.3) 24 (7.1) 21 (8.9) 3 (3.0)
Vancomycin 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
aIn accordance to Performance Standards for Antimicrobial Disk Susceptibility Tests, NCCLS (1998, 1999, 2000, 2002).
bAtleast one antimicrobial agent assayed from a particular class of antibiotics.
cThe intermediate resistant category was included in sensitive category.
d(trimethoprim/sulphamethoxazole).
eMethicillin resistance was confirmed by Oxacillin Salt-agar screening – plate procedureAnnals of Clinical Microbiology and Antimicrobials 2006, 5:22 http://www.ann-clinmicrob.com/content/5/1/22
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admitted in the postoperative ward of the Institute of
Ophthalmology. JN-49 strain (AR, PR, CfR, ER, GS, TS) was
isolated from the nose of the same patient having postop-
erative ocular infection and JS-105 (TR, ER, GR, AS, PS, CfS)
was isolated from ocular swab.
PFGE
Chromosomal DNA from MRSA isolates was prepared in
agarose blocks and was cleaved with SmaI (Bangalore
Genei Pvt. Ltd. India) as described by Bannerman et al
[40]. PFGE typing of clinical and carrier MRSA strains iso-
lated during our study was performed as described previ-
ously [39,41]. For restriction endonuclease digestion,
approximately 1 to 1.5 mm of a plug was cut and incu-
bated with 250 µl of restriction buffer containing 20 U of
SmaI at 25°C for 4 h. After DNA digestion, the agarose
plugs were incubated with 1 ml of TE buffer at 37°C for 1
h. The plugs were then inserted into 1% agorose gel in
0.5× TBE buffer, and restriction fragments were separated
using a contour-clamped homogeneous electric field sys-
tem (CHEF-DRII; Bio-Rad, Laboratories). Electrophoresis
was performed using the following conditions: Block 1:
initial switch time 5 sec; final switch time 15 sec; run time
10 h; voltage 200 V or 6 V/cm. Block 2: initial switch time
15 sec, final switch time 60 sec. run time 13 h, voltage 20
V or 6 V/cm.
Table 2: Antibiotic resistance profiles of 61 strains of MRSA isolated in an orthopaedic surgical ward
Pattern Antibiotic resistance profiles of MRSA No. of resistance markers Strains
1. A,Cz,Ce,Cp,Co,G,I,M,P,R,Ro,T 12 JMR-1
2. Ak,A,Cz,Ce,Cp,Cf,Cd,Co,G,I,M,P,Ro 13 JMR-2
3. Ak,A,Cz,Ce,Cp,Co,G,I,M,P,Ro 11 JMR-3, 55, 33, 59
4. A,Cz,Ce,Cp,Cd,Co,G,I,M,P,T 11 JMR-4
5. A,Cz,Ce,Cp,Cd,Co,G,M,P 9 JMR-5
6. A,Cz,Ce,Cp,Cf,Cd,Co,G,M,P,R,Ro 12 JMR-6, 38, 51
7. A,Cz,Ce,Cp,Cf,Co,M,P,R,Ro 10 JMR-7
8. Ce,Cd,Co,M,P,R 6 JMR-8
9. A,Cz,Ce,Cp,C,Cd,Co,M,P,R 10 JMR-9
10. Ak,A,Cz,Ce,Cp,Cf,Co,G,M,P,R,Ro,T 13 JMR-10
11. Ak,A,Cz,Ce,Cp,Cd,Co,G,M,P,R,Ro 12 JMR-11, 53
12. Ak,A,Cz,Ce,Cf,Cd,Co,G,I,M,P,R,Ro 13 JMR-12
13. A,Cz,Ce,Cp,Cd,Co,G,M,P,R 10 JMR-13
14. A,Cz,Ce,Cp,Co,M,P,R 8 JMR-14
15. A,Cz,Ce,Cp,Cf,Co,G,M,P,R 10 JMR-15, 58
16. A,Cz,Ce,Cp,Cf,Co,G,M,P 9 JMR-16
17. Ak,A,Cz,Ce,Cp,Cd,Co,G,M,P,R 11 JMR-17
18. A,Cz,Ce,Cp,Co,G,M,P,R 9 JMR-18
19. Ak,A,Cz,Ce,Cp,Co,G,M,P,Ro 10 JMR-19, 61
20. Ak,A,Cz,Ce,Cp,Cd,Co,G,I,M,P,R,Ro 13 JMR-20
21. A,Ce,Cp,C,Co,G,M,P,T 9 JMR-21
22. Ak,A,Cz,Cp,Co,G,I,M,P,Ro,T 11 JMR-22
23. A,Cz,Ce,Cp,Co,G,M,P,Ro 9 JMR-23
24. Ak,A,Cz,Ce,Cp,Cf,Cd,Co,G,M,P,Ro,T 13 JMR-24, 46, 48, 39
25. Ak,A,Cz,Ce,Cp,C,Cf,Co,Fc,G,I,M,R,Ro,T 15 JMR-25
26. A,Cz,Ce,Cp,Co,G,M,P,Ro,T 10 JMR-26, 52
27. A,Cz,Ce,Cp,Co,G,M,P,Ro,T 10 JMR-27
28. Ak,A,Cz,Ce,Cp,C,Cf,Cd,Co,Fc,G,I,M,P,R,Ro,T 17 JMR-28, 60
29 A,Cz,Ce,Cp,C,Cd,Co,G,M,P,R,Ro,T 13 JMR-29
30. A,Cz,Ce,Cp,Co,G,I,M,P,R,Ro 11 JMR-30
31. Ce,Cp,Cd,Co,M,P 6 JMR-31, 56
32. A,Cz,Ce,Cp,Cf,Co,G,M,P,R,Ro,T 12 JMR-32
33. A,Cz,Ce,Cp,C,Cf,Cd,G,Co,I,M,P,Ro,T 14 JMR-34
34. A,Cz,Ce,Cp,C,Co,G,M,P,Ro,T 11 JMR-35
35. Ak,A,Cz,Ce,Cp,C,Co,G,M,P,R,Ro 12 JMR-36, 49
36. Cz,Ce,Cp,Cd,Co,M,P 7 JMR-37, 45, 50, 54
37. A,Cz,Ce,Cp,Cf,Co,M,P,R 9 JMR-40
38. A,Cz,Ce,Cp,C,Cf,Cd,Co,Fc,G,I,M,P,R,Ro,T 16 JMR-41
39. Ak,A,Cz,Cp,I,M,P,Ro 8 JMR-42
40. A,Cz,Ce,Cp,Cd,Co,G,M,P,R,Ro 11 JMR-43
41. A,Cz,Ce,Cp,Cf,Co,G,M,P,Ro 10 JMR-44
42. A,Cz,Ce,Cp,Co,G,M,P,Ro 9 JMr-47, 57Annals of Clinical Microbiology and Antimicrobials 2006, 5:22 http://www.ann-clinmicrob.com/content/5/1/22
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Results
Age and gender distribution
Of the 750 subjects studied the male: female ratio was
52.5:47.5, of whom 175 were normal hospital workers
(Table 5). The age range was 5 to 75 years. Of these 12
cases of mastatitis belonged exclusively to females and 18
cases of prostatitis to men. Of patients having wound
infections (n = 122), the highest prevalence of Staphylo-
cocci (27%) was found in the age group of 45–64 years
and so was the case with patients having urinary tract
infections (32.6%). In this study Staphylococcal conjunc-
tivitis was found equally prominent in the age group of 5–
14 (23.1%) and 45–64 (23.1%) years. Of the 175 normal
hospital workers, the highest number of carrier Staphylo-
cocci (48%) were isolated from the subjects having age
between 25 and 44 years where as the age group 5–14
years contributed none. In the present study we were hav-
ing no information regarding the age of 52 subjects and so
they were categorized as unknown age group.
Frequency of staphylococcal isolates among clinical 
sources
Of the 850 clinical strains of staphylococci studied (Table
1), 60.3% were Staphylococcus aureus and 39.7% coagu-
lase-negative staphylococci. Of these 35.1% were methi-
cillin-resistant Staphylococcus aureus (MRSA) and 22.5%
were methicillin-resistant coagulase-negative staphyloco-
cci (MRCNS). The highest number of S. aureus strains was
isolated from pus (22.7%) followed by urine (14.8%) and
blood (11.3%) (Figure 1). Likewise, the highest number
of coagulase-negative staphylococcal isolates was found
in urine (22.8%) followed by conjunctivitis (16.3%) and
pus (10.7%). Of the 225 nasal swabs of hospital workers
and patients studied, 34.1% were S. aureus and 14.8%
were coagulase-negative staphylococci, where as from
ocular swabs (n = 50) of hospital workers all the strains
studied were coagulase-negative staphylococci. Of the 180
MRSA strains the highest number was found in pus
(35.5%) followed by urine (16.1%) and blood (9.4%). In
Distribution of staphylococcal isolates among the clinical sources Figure 1
Distribution of staphylococcal isolates among the clinical sources. Out of 151 isolates from pus, 115 were S. aureus 
and 36 were coagulase-negative staphylococci (CNS). Likewise, of 153 isolates from urine, 77 were CNS and 76 were S. aureus. 
Of the 225 nasal swabs of hospital workers and patients studied, 175 (34.1%) were S. aureus and 50 (14.8%) were CNS.
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case of nasal swabs of hospital workers and patients (n =
225) the frequency of MRSA isolates was 28.9% that is
equivalent to MRSA carrier rate of 23.1%. Of the 76
MRCNS studied the highest number was obtained from
urine (25.0%) followed by conjunctiva (18.4%) and nasal
swabs of patients having ocular infections (14.5%), where
as 10.5% of MRCNS were isolated from ocular swabs of
hospital workers.
Resistance Profiles of Staphylococcal Isolates
The resistance patterns of staphylococcal isolates (n =
850) to 18 antimicrobial agents are shown in Table 1.
Vancomycin appeared to be the most effective drug. In
case of Staphylococcus aureus (n = 513), the highest resist-
ance was observed to penicillin G (92.0%) followed by
ampicillin (80.5%) and co-trimoxazole (50.0%). Though
the highest resistance in coagulase-negative staphylococci
(n = 337) was shown to penicillin G (89.9%) but it was
lesser by (2.1%) as compared to its resistance in Staphylo-
coccus aureus, followed by the same pattern as to ampicil-
lin (71.5%) and co-trimoxazole (40.3%).
As far as the clinical versus carrier staphylococcal islates
are concerned the general observation was that the resist-
ance in carrier isolates was lesser than clinical strains in
case of all antibiotics. In clinical (n = 338) and carrier (n
= 175) isolates of S. aureus the highest resistance was
found to penicillin G (92.6% versus 90.60%) followed by
ampicillin (81.4% versus 78.8%) and co-trimoxazole
(51.8% versus 46.3%) respectively. The least resistance
was shown to fusidic acid (4.1% versus 2.3) followed by
chloramphenicol (4.7% versus 3.4%), tetracycline
(12.7% versus 7.1%) and amikacin (13.9% versus 10.3%)
respectively in clinical and carrier isolates of S. aureus.
Almost similar trend was observed in clinical (n = 237)
and carrier (n = 100) isolates of coagulase-negative sta-
phylococci, with the exception that in carrier isolates zero
resistance to amikacin was seen.
Comparative multi-drug resistance patterns of methicillin-
resistant and methicillin-sensitive clinical and carrier 
isolates
Resistance to 4 antibiotics or more was observed in both
S. aureus and Coagulase-negative staphylococci. In case of
MRSA isolates, no strain showed resistance to 5 or less
than 5 antibiotics, where as all MRCNS strains showed
resistance to 8 or more than 8 antibiotics. As far as the
clinical and carrier MRSA are concerned, in the present
study, both types of strains showed resistance to 6 or more
than 6 antibiotics assayed (Fig 2). In case of clinical and
carrier methicillin-sensitive S. aureus (MSSA) isolates, no
strain showed resistance to more than 7 antibiotics.
Almost same trend of multidrug resistance patterns was
observed in case of clinical and carrier, MRCNS and
MSCNS isolates from eye and other clinical sources in
health and diseases (Fig 3).
Antibiotic resistance profiles of MRSA isolates in an 
orthopedic surgical ward
In this study, 61 isolates turned to be MRSA, were isolated
in an Orthopaedic Surgical Ward from wound infections
(n = 56); their nose (n = 50); and nose of hospital workers
attending wound infections (n = 50). As depicted in Table
2, MRSA isolates, JMR-8, 31, 56 showed resistance to 6
antibiotics; and one strain showed resistance to 16 antibi-
otics (JMR-41), and two strains showed resistance to max-
imum of 17 antibiotics (JMR-28, 60) assayed in the
present study. Antibiotic resistance patterns, 3, 24, and 36
were the most common profiles found by 4 strains each in
this study.
PFGE profiles of MRSA
The 14 common methicillin – resistant S. aureus (MRSA)
patterns were identified among 61 stains of MRSA isolated
in the Orthopedic Surgical Ward (figure 4). The patterns
were designated by the letters A to N based on difference
in banding patterns. The banding type A was shown by
highest number of MRSA strains (n = 7), where as type I
was shown by only one MRSA isolate (Table 3). These
results indicated that typing can be performed effectively
through molecular techniques such as PFGE patterns but
Table 4: Minimal inhibitory concentrations of A, G, Ak for S. 
aureus strain JMR10 and one E. coli transformant
Strain MIC (µg/ml)
AG A k
S. aureus strain JMR10 800 1000 200
E. coli 11 3
E. coli transformants 200 100 400
Table 3: PFGE patterns of 61 MRSA isolates
Banding pattern Strains Number of isolates
A JMR-1, 2, 3, 4, 6, 38, 55 7
B JMR-5, 14, 18 3
C JMR-9, 13, 19, 26, 52 5
D JMR-16, 25, 29 3
E JMR-24, 46, 48, 39 4
F JMR-31, 56 2
G JMR-37, 50, 54, 15, 58 5
H JMR-21, 40, 42, 44, 59, 61 6
I JMR-8 1
J JMR-17, 20, 23, 27, 30, 32, 6
K JMR-11, 12, 28, 41, 53 60, 6
L JMR-22, 33, 34, 35, 36 5
M JMR-43, 45, 51 3
N JMR-7, 10, 47, 49, 57 5A
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Table 5: Age and gender distribution of staphylococcal infected/colonized subjects (n = 750) according to clinical diagnosis
Clinical Diagnosis
n = 750 (100%)
Age (Y)
5–14 n = 63 (%) 15–24 n = 133 (%) 25–44 n = 224 (%) 45–64 n = 182 (%) >65 n = 96 (%) Unknowna n = 52 (%)
Male
n = 31(49.2)
Female
n = 32(50.8)
Male
n = 67(50.4)
Female
n = 66(49.6)
Male
n = 116(51.8)
Female
n = 108(48.2)
Male
n = 101(55.5)
Female
n = 81(44.5)
Male
n = 56(58.3)
Female
n = 40(41.7)
Male
n = 23(44.2)
Female
n = 29(55.8)
Wound infection
n = 122 (16.2)
8 (12.7) 5 (7.9) 16 (12.0) 14 (10.5) 16 (7.1) 7 (3.1) 17 (9.3) 16 (8.8) 9 (9.4) 7 (7.3) 2 (3.8) 5 (9.6)
Postoperative infection
n = 35 (4.7)
1 (1.6) 2 (3.2) 2 (1.5) 1 (0.7) 2 (0.9) 8 (3.6) 4 (2.2) 5 (2.7) 8 (8.3) 2 (2.1) - -
Bacteraemia
n = 25 (3.3)
1 (1.6) 1 (1.6) - 2 (1.5) 4 (1.8) 2 (0.9) 7 (3.8) 4 (2.2) 1 (1.0) - 2 (3.8) 1 (1.9)
Pneumonia
n = 21 (2.8)
5(7.9) 1 (1.6) 1 (0.7) - 1 (0.4) 1 (0.4) 1 (0.5) 2 (1.1) 3 (3.1) 1 (1.0) 3 (5.8) 2 (3.8)
Septicaemia
n = 15 (2.0)
- - 1 (0.7) 1 (0.7) 1 (0.4) 2 (0.9) 2 (1.1) 2 (1.1) 1 (1.0) - 2 (3.8) 3 (5.8)
Urinary tract infections
n = 89 (11.9)
- 1 (1.6) 4 (3.0) 5 (3.8) 10 (4.5) 15 (6.7) 14 (7.7) 15 (8.2) 9 (9.4) 11(11.5) - 5 (9.6)
Mastatitis
n = 12 (1.6)
- - - 2 (1.5) - 8 (3.6) - 2 (1.1) - - - -
Prostatitis
n = 18 (2.4)
- - 1 (0.7) - 5 (2.2) - 9 (4.9) - 3 (3.1) - - -
Conjunctivitis
n = 52 (6.9)
7 (11.1) 5 (7.9) 5 (3.8) 4 (3.0) 1 (0.4) 4 (1.8) 7 (3.8) 5 (2.7) 4 (4.2) 5 (5.2) 3 (5.8) 2 (3.8)
Corneal ulcer
n = 20 (2.7)
1 (1.6) - 2 (1.5) - 2 (0.9) 1 (0.4) 2 (1.1) 3 (1.6) 3 (3.1) 2 (2.1) 1 (1.9) 3 (5.8)
Endophthalmitis
n = 11 (1.5)
- - 1 (0.7) - - 1 (0.4) 2 (1.1) 2 (1.1) 2 (2.1) 1 (1.0) 1 (1.9) 1 (1.9)
Otherb 
n = 110 (14.7)
8 (12.7) 13 (20.6) 11 (8.3) 13 (9.8) 12 (5.3) 8 (3.6) 12 (6.6) 8 (4.4) 11 (11.5) 9 (9.4) 3 (5.8) 2 (3.8)
Normalc 
n = 175 (23.3)
- - 20 (15.0) 18 (13.5) 56 (25.0) 46 (20.5) 16 (8.8) 15 (8.2) - - 2 (3.8) 2 (3.8)
Unknownd 
n = 45 (6.0)
- 4 (6.3) 3 (2.2) 6 (4.5) 6 (2.7) 5 (2.2) 8 (4.4) 2 (1.1) 2 (2.1) 2 (2.1) 4 (7.7) 3 (5.8)
aAge not recorded for 52 subjects.  
bAbscess or osteomyelitis, cystitis, peritonitis, endocarditis, toxic shock syndrome, keratitis, etc.  
cStrains isolated from nose of hospital workers attending wound infections (n=50), nose of hospital workers (n=75) and normal eyes of hospital  workers (n=50) respectively in Orthopaedic 
Surgical Ward of J.N Medical College, A.M.U., Aligarh, S.K. Institute of Medical Sciences Kashmir  and Surgical Wards of Institute of Ophthalmology, A.M.U. Aligarh.  
dClinical diagnosis not recorded for 45 subjects.Annals of Clinical Microbiology and Antimicrobials 2006, 5:22 http://www.ann-clinmicrob.com/content/5/1/22
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not through antibiograms as 61 strains showed 42 antibi-
ograms that were narrowed down to only 14 types by
PFGE. Moreover, it is evident that the MRSA strains which
display a common antibiogram can not necessarily show
the same PFGE pattern, for example, JMR-3, 55, 33, 59
showed antibiogram 3 (Table 3) but JMR-33 showed
PFGE pattern L and JMR-59 showed PFGE pattern H
although both JMR-3 and JMR-55 showed the same PFGE
pattern A.
Molecular typing by PFGE of SmaI-digested DNA from
MRSA strains isolated from eight patients having postop-
erative wound infections admitted in Orthopedic Surgical
Ward was performed (Fig 5). The staphylococcal strains
were isolated from pus, skin and nose of the patients. The
criteria proposed by Tenover et al [41] were employed to
analyze the DNA fingerprints generated by PFGE. PFGE
patterns are indistinguishable between MRSA from the
nasal cavity (A1, A1), and pus (A1, A1) but the pattern is
different for MRSA from the skin (B, E) nearby wounds for
cases 1 and 8, respectively. PFGE patterns are indistin-
guishable between MRSA from the nasal cavity (C1) and
Pus (C1) and closely related to that of MRSA from the skin
(C2) for case 2 (Fig. 5). PFGE patterns are indistinguisha-
ble between MRSA from the skin (C4) and pus (C4) but
closely related to that of MRSA from the nasal cavity (C2)
for case 7. The patterns of MRSA isolates from the pus,
skin and nasal cavity are indistinguishable for cases 3 (A2,
A2, A2), 4 (C3, C3, C3), 5 (C3, C3, C3) and 6 (D, D, D).
These results indicated that self-infection through coloni-
zation needs to be taken into consideration and the
appropriate measures should be followed to minimize the
role of carrier isolates in postoperative infections.
Furthermore the bacteria that normally colonize the
human body (the resident microflora) could act as reser-
voirs for resistance genes, which could then be transferred
to pathogens during their temporary colonization of the
same site, and need to be focused while treating infec-
tions.
Plasmid-determined resistance transfer
The E. coli (DH5α), which was earlier sensitive to Ampicil-
lin (A), Gentamicin (G) and Amikacin (Ak), now acquired
Occurrence of multidrug resistance in methicillin-resistant and methicillin-sensitive S. aureus clinical and carrier isolates Figure 2
Occurrence of multidrug resistance in methicillin-resistant and methicillin-sensitive S. aureus clinical and carrier isolates.
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resistance to these three antibiotics after transformation of
plasmid pJMR-10 into it. Again plasmid was isolated from
transformed  E. coli (DH5α) and the isolated plasmid
preparation from S. aureus (JMR-10) and transformed E.
coli (DH5α) were loaded in 0.7% agarose gel. From Fig. 6
it appeared that the 4.3 kb plasmid from S. aureus (Lane
A) was transformed to E. coli (Lane C). Minimum inhibi-
tory concentrations of A, G, Ak on S. aureus strain JMR-10
and E. coli transformant indicated (Table 4) that the MIC
for Ak was higher in E. coli than S. aureus and may be due
to the fact that Ak resistance gene was very efficiently
expressed in E. coli.
Plasmids were electrophoresed (Fig. 7) after isolation
from JN-49 (Lane A), JS-105 (Lane B), and transconjugant
JNS-1 (Lane E). Here transconjugants were screened as
(AR, TR). The transconjugant JNS-1 was subjected to curing
treatment with ethedium bromide. Three types of cured
transconjugents were obtained. As shown in figure 7 cured
transconjugant JNS-IA (Lane C), having 38 Kb plasmid
showed resistance pattern as GR, ER, CfR, TS, AS, PS. Simili-
marly cured transconjugant JNS-IB (Lane D), having no
plasmid depicted resistance profile as ER, CfR, TS, GS, AS,
PS. Likewise, cured transconjugant JNS-IC (Lane F), hav-
ing 4.4 Kb plasmid, displayed resistance pattern as TR, CfR,
ER, GS, AS, PS. The conjugation experiments clearly showed
that resistant markers G and T got transferred from clinical
S. aureus (JS-105) to carrier S. aureus (JN-49). Moreover
the ciprofloxacin (Cf) and erythromycin (E) resistance
seemed to be chromosomal mediated as evidenced in
Lane D.
Discussion
There are reports of emergence and high occurrence of
strains resistant to methicillin from various parts of the
world [29]. Recent studies have documented the increased
costs associated with MRSA infection, as well as the
importance of colonization pressure [42,43]. Already
multiresistant to different classes of antibiotics, MRSA had
been reported to acquire resistance to gentamicin and
related aminoglycosides [30], therefore the treatment of
infections due to these organisms and their eradication is
very difficult. Constant monitoring of these strains is
essential in order to control their spread in the hospital
Occurrence of multidrug resistance in methicillin-resistant and methicillin-sensitive coagulase-negative staphylococcal clinical  and carrier Isolates Figure 3
Occurrence of multidrug resistance in methicillin-resistant and methicillin-sensitive coagulase-negative staphylococcal clinical 
and carrier Isolates.
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environment and transmission to the community. Of the
513 clinical strains of S. aureus, 180 (65.1%) were methi-
cillin-resistant S. aureus (MRSA) and out of 337 coagulase-
negative staphylococcal isolates 76 (22.5%) were methi-
cillin-resistant (MRCNS). Of the 180 MRSA strains the
highest number was found in pus followed by urine and
blood. Of the 76 MRCNS studied the highest number was
obtained from urine followed by conjunctiva and nasal
swabs of patients having ocular infections. The number of
MRSA isolates being drastically high in wound infections,
this might be due to the fact that orthopedic unit is a fer-
tile environment for MRSA. The open wounds and the fre-
quent dressing changes often necessitate a dressing team
or multiple persons plus the inherent immunosupression
of the wound patients might lead to MRSA colonization.
The present study suggests that MRSA most likely remains
a hospital-acquired infection, but a significant proportion
may be acquired in community facilities like nursing and
residential homes [43]. The major reservoir of staphyloco-
cci in hospitals are colonized/infected in-patients and col-
onized hospital workers, with carriers at risk for
developing endogenous infection or transmitting infec-
tion to health care workers and patients [2,3,17-19,44],
while transient hand carriage of the organism on the
hands of health care workers account for the major mech-
anism for patient to patient transmission [20]. Low prev-
alence of MRSA colonization in an adult outpatient
population indicated that MRSA carriers most likely
acquired the organism through contact with healthcare
facilities rather than in the community [45]. These data
show that care must be taken when attributing MRSA col-
onization to the community if detected in outpatients or
during the first 24 to 48 hours of hospitalization. The risk
to patients in terms of transmission of MRSA seems to be
influenced strongly by the proportion of patients with col-
Pulsed-field gel electrophoresis (PFGE) profiles of MRSA Figure 4
Pulsed-field gel electrophoresis (PFGE) profiles of MRSA. Fourteen MRSA fingerprint patterns were identified for the 
61 strains of MRSA isolated in an Orthopaedic Surgical Ward. These strains were collected from wound infections (n = 56); 
patient's nose (n = 50); and nose of the hospital workers attending wound infections (n = 50). Lanes 1, 9 and 17 represent S. 
aureus 8325 patterns for comparison.  Lanes 2 to 16 barring 9 respectively represent PFGE banding patterns A to N.Annals of Clinical Microbiology and Antimicrobials 2006, 5:22 http://www.ann-clinmicrob.com/content/5/1/22
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onization at intensive care unit admission and is associ-
ated with severity of illness, length of stay, and exposures
to antibiotics and medical devices [46].
Colonization with S. aureus can occur soon after birth and
at any given time, the nasal carriage rate in adults is esti-
mated at between 20% and 40% [47]. Healthcare workers
have a higher incidence of colonization. The carrier state
is clinically important because carriers undergoing surgery
will experience more infections than non-carriers. Fierobe
et al [42] has shown a relationship between MRSA postop-
erative intra-abdominal sepsis and nasal colonization of
MRSA. MRSA strains are usually introduced into an insti-
tution by an infected or colonized patient or by a colo-
nized healthcare worker, and transfer from one patient to
another has led to major epidemics in tertiary care hospi-
tals as well as chronic care facilities [3]. Colonization of
anterior nares with MRSA carries a significantly higher risk
for infection than does colonization by sensitive strains
[18,47].
It is imperative we continue with basic infection control
principles like hand washing and contact isolation and
barrier nursing. Intranasal 2% mupirocin applied twice
daily for five days appears to be the most effective topical
agent against MRSA [48-50] and eliminates 91% of stable
carrier states. By confining the investigation to nasal car-
riage in healthy state, colonization at other body sites may
have remained undetected and the 'true' prevalence in this
study may have been underestimated. There is, however,
overall agreement that sensitivity of nose swabs in detect-
ing MRSA carriage is reasonably high (>70%) [51-53], and
it was decided to confine the investigation to nasal speci-
mens for reasons of accessibility, compliance and consist-
ency with other investigations. The design of the study
does not allow one to distinguish between patients who
Pulsed-field gel electrophoresis (PFGE) of MRSA clinical isolates Figure 5
Pulsed-field gel electrophoresis (PFGE) of MRSA clinical isolates. PFGE patterns were indistinguishable between 
MRSA from the nasal cavity (na) and pus (ps) but the patterns were different for MRSA from the skin (s) and nearby wounds 
for cases 1 and 8. PFGE patterns were indistinguishable between MRSA from the nasal cavity and pus and closely related to 
that of MRSA from the skin for case 2. PFGE patterns were indistinguishable between MRSA from the skin and pus but closely 
related to that of MRSA from the nasal cavity for case 7. The patterns of MRSA isolates from the nasal cavity, skin, and pus 
were indistinguishable for cases 3, 4, 5, & 6.Annals of Clinical Microbiology and Antimicrobials 2006, 5:22 http://www.ann-clinmicrob.com/content/5/1/22
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acquired MRSA during their current episode of hospital
stay or patients already colonized on arrival to the hospi-
tal. Despite this, most of the carriers appeared to have
acquired the organisms in hospital settings, as most of the
isolates seem to be of the same types of strains as isolated
from nose of the hospital workers.
From this study we suggest that all patients having history
of previous hospital admission and patients admitted
directly from nursing homes should be screened for MRSA
prior to any elective surgical or orthopedic operative pro-
cedures. We believe that patients for routine elective pro-
cedures should have a negative result before undergoing
the procedure. If surgery cannot be delayed due to medical
reason then prophylaxis against MRSA should be given
prior to the operation, though we appreciate this may not
have much benefit in case of emergency admissions.
However we would suggest that in patients with any of the
above risk factors admitted for emergency surgery which
may involve prosthetic implant, should be screened as
well as given MRSA prophylaxis prior to their operations.
Broad-spectrum insusceptibility of all 180 MRSA and 76
MRCNS isolates to common antimicrobial agents were
observed. Among all 17 antimicrobial agents used only
vancomycin was shown to be consistently effective against
all MRSA and MRCNS. We did not find any glycopeptide
resistant S. aureus in our study, and vancomycin and teico-
planin remain the drugs of choice, although decreased
susceptibility as well as resistance to vancomycin has been
reported recently [54,55].
Of the 850 stephylococcal isolates, surprisingly about
90%, 80% and 50% strains were resistant to Pencillin G,
ampicillin and co-trimoxazole, respectively. This might be
due to the fact that at present time these agents are tre-
mendously used in the treatment of general infections.
On the contrary to the multiple resistance of MRSA, MSSA
seemed to be much more susceptible to all tested antimi-
crobial agents except for pencillin, ampicillin and co-tri-
moxozable. Our observation was that resistance in carrier
isolates was lesser than clinical strains in case of all antibi-
otics tested. In the present study it is documented that
resistance to chloramphenicol and ciprofloxacin was
comparatively higher in ocular isolates as compared to
staphylococcal strains isolated from other clinical sources.
This might be due to more pronounced use of these anti-
biotics for treatment of ocular infections. This study
underscores the need for hospital clinicians to be aware of
the common bacterial isolates in their unit and their usual
antibiotic susceptibility. This is imperative in order to
make rational decisions for the prudent use of antibiotics,
particularly for empirical therapy. Another important
cause of resistance is excessive or inappropriate use of
antibiotics in hospitals [56]. The magnitude of the prob-
lem of multi-resistance is such that clinicians must be
familiar with the causes of antibiotic resistance and the
measures for preventing or minimizing the emergence of
resistance.
PFGE, because of its great discriminatory power and high
degree of specimen typeability is accepted as the gold
standard for the molecular typing of S. aureus isolates. It
has successfully been used to study the epidemiology of S.
aureus  nosocomial infection and methicillin resistance
[40,57-59]. Nevertheless, PFGE is time-consuming and
labor intensive, in this study PFGE exhibited superiority as
a technique for analyzing epidemiology of S. aureus. In
the present study it was observed that the 61 strains of
MRSA isolated in an Orthopaedic Surgical Ward displayed
42 patterns of antibiogram. These 61 MRSA strains were
subjected to PFGE analysis whereby 14 PFGE patterns
were observed. These results suggest that most of the
MRSA appeared to have been acquired by patients during
their current episode of hospital stay. Moreover similarity
of PFGE patterns of MRSA isolates from pus, skin and
nasal cavity suggest that most MRSA types isolated from
pus were derived from the nasal cavity but some types
were derived from the nearby skin and that these microor-
ganisms occasionally cause wound infections.
Agarose gel electrophoresis of crude plasmid DNA Figure 6
Agarose gel electrophoresis of crude plasmid DNA. 
Lane A, MRSA, resistant to A, G and Ak, having 4.3 kb plas-
mid (pJMR10); Lane B, E. coli (DH5α) sensitive to A, G, and 
Ak; Lane C, Transformant E. coli (DH5α) having 4.3 kb plas-
mid; Lane D, S. aureus RN834, containing the plasmid molec-
ular markers.Annals of Clinical Microbiology and Antimicrobials 2006, 5:22 http://www.ann-clinmicrob.com/content/5/1/22
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MRSA acquisition depends on 2 major and independent
determinants: colonization pressure and antimicrobial
selective pressure. In case of colonization with distinct
multiple clones of MRSA, antimicrobial pressure plays a
major role; in the case of colonization with a single dom-
inant clone of MRSA, colonization pressure plays a major
role. McGown [60] proposed a biological model to
explain the relationship between antimocrobial use and
the emergence of resistance. At the level of individual
patient, antimicrobial treatment leads to a large modifica-
tion in the endogenous flora. The usual result is that sus-
ceptible strains are replaced by resistant ones. At the
collective level, antimicrobial use in a hospital unit tends
to maintain the presence of multidrug – resistant organ-
isms in inpatients, healthcare workers, and the environ-
ment. In cases in which basic infection-control practices
are inconsistently applied, these pathogens are implicated
in the majority of infections. Antimicrobials such as β-
lactams and fluoroquinolones, which are ineffective
against MRSA and have excellent tissue diffusion, could
promote the acquisition of MRSA by increasing the 'recep-
tiveness' of the patients and thereby allowing the progres-
sion towards colonization and infection.
The spread of resistance to antimicrobial agents in S.
aureus is largely due to the acquisition of plasmids and/or
transposons [61]. Although transfer of resistance between
staphylococcal strains in the laboratory has been shown
to occur via transformation, transduction, and conjuga-
tion [62] only conjugative transfer appears to be signifi-
cant in vivo [63]. In staphylococci, the conjugative
transfer of resistant determinants is usually mediated by
conjugative plasmids [64] but has also been shown to
occur in the absence of detectable conjugative plasmids
[65]. Conjugative plasmids, usually 35 to 50 kb, spread
resistance determinants between species and genera
[66,67]. Besides transferring the resistance determinants,
they can mobilize non-conjugative plasmids [64] recom-
bine with nonconjugative plasmids to form new plasmids
or acquire and transfer resistance transposons [61,63].
Studies with human staphylococcal strains indicate that
Staphylococcus epidermidis is a reservoir of antibiotic resist-
ance genes that can be transferred to S. aureus under in
vitro and in vivo conditions [64]. In vitro studies of drug
resistance transfer between clinical and carrier staphyloco-
ccal strains, was done in the present study. The results
indicated that tetracycline resistance was transferred from
clinical to carrier isolates. This reflects that the use of anti-
biotics in humans to treat infections can promote resist-
ance in normal flora.
The widespread occurrence and dissemination of resist-
ance markers leading to multiple antibiotics ineffective,
thus increasing the cost of health care, needs to be tackled
logistically by wise and judicious use of existing antibiot-
ics and by developing ideal and cost effective antibiotics
having least chances of acquiring resistance. Furthermore
the hospital acquired MRSA infections through coloniza-
tion of patients and hospital workers demands appropri-
ate and timely measure to counteract this health problem.
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